APA (7th ed.) Citation

A, E., D, R., SS, Z., P, A., G, H., GYH, L., . . . U, A. (2025). Addressing methodological considerations in the assessment of the effect of SGLT2 inhibitors and GLP-1 receptor agonists on diabetic eye complications. Reply to Tsai Y-H, Hemphill NO, Kurth T. Diabetologia, 68(1), 249. https://doi.org/10.1007/s00125-024-06314-1

Chicago Style (17th ed.) Citation

A, Eleftheriadou, Riley D, Zhao SS, Austin P, Hernández G, Lip GYH, Jackson TL, Wilding JPH, and Alam U. "Addressing Methodological Considerations in the Assessment of the Effect of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Diabetic Eye Complications. Reply to Tsai Y-H, Hemphill NO, Kurth T." Diabetologia 68, no. 1 (2025): 249. https://doi.org/10.1007/s00125-024-06314-1.

MLA (9th ed.) Citation

A, Eleftheriadou, et al. "Addressing Methodological Considerations in the Assessment of the Effect of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Diabetic Eye Complications. Reply to Tsai Y-H, Hemphill NO, Kurth T." Diabetologia, vol. 68, no. 1, 2025, p. 249, https://doi.org/10.1007/s00125-024-06314-1.